Cost-Benefit Analysis Of Special Care And Diabetes Control By Bose Hospital In Tirunelveli, Tamil Nadu

Abstract

This study assesses the effectiveness and financial viability of a diabetes care program through a comprehensive analysis of patient demographics, clinical measures, cost trends, and patient experiences. Patients in the program had a mean age of 52.3 years, with a slight male predominance (54%) and a majority from middle-income backgrounds (45%). Clinical outcomes show significant improvement in glycemic control, with mean HbA1c decreasing from 8.2% to 7.1% over the study period. Time series analysis reveals a consistent annual decrease in HbA1c levels and a stabilization of cost increases after the initial implementation phase. Economic evaluations indicate a positive net present value (₹50 million), a benefit-cost ratio of 1.8, and an 80% return on investment, supporting the program's financial viability. The cost-effectiveness analysis, with an incremental cost-effectiveness ratio (ICER) of ₹120,000 per QALY gained, confirms the program's cost-effectiveness. Comparative statistics show significant reductions in both microvascular (30%) and macrovascular (25%) complications. Survival analysis demonstrates that the intervention group experienced a median time to the first complication of 8.5 years, significantly longer than the historical control group. Multivariate analysis identifies glycemic control, treatment adherence, and Socio--economic factors as key contributors to the program's success. Sensitivity analysis indicates that medication costs and complication rates are critical factors affecting cost-effectiveness. The quality of life analysis shows a significant improvement in EQ-5D scores. Patient feedback indicates high satisfaction with the program and suggests that subsidized medication and lower consultation fees could further reduce financial burdens. Overall, the study highlights the program's substantial benefits in improving patient outcomes and managing costs, while also identifying areas for potential enhancement to support patient financial sustainability.